{"id":"W2038739693","doi":"10.1017/s026646230505066x","title":"Ximelagatran: A new type of oral anticoagulant","year":2005,"lang":"en","type":"review","venue":"International Journal of Technology Assessment in Health Care","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); University Health Network","funders":"","keywords":"Ximelagatran; Medicine; Direct thrombin inhibitor; Warfarin; Cochrane Library; Stroke (engine); Anticoagulant; Atrial fibrillation; Discovery and development of direct thrombin inhibitors; Intensive care medicine; Dabigatran; Randomized controlled trial; Surgery; Internal medicine; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006529001,0.0003610431,0.0009022789,0.003547951,0.0002159047,0.002359381,0.0003920655,0.001003318,0.005297473],"category_scores_gemma":[0.007759523,0.0001330201,0.0008910223,0.002976266,0.000559388,0.002021316,0.000518133,0.0006023162,0.0005601427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00102794,"about_ca_system_score_gemma":0.002357943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000481375,"about_ca_topic_score_gemma":0.001483567,"domain_scores_codex":[0.9956131,0.001207308,0.001031242,0.0003649383,0.001698109,0.00008522232],"domain_scores_gemma":[0.9922957,0.003670113,0.002589245,0.0001880763,0.001035341,0.0002214207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002729288,0.0002322927,0.03678533,0.03272509,0.001517093,0.0008072126,0.0002150724,0.0002647697,0.003146678,0.004125985,0.004633761,0.9128175],"study_design_scores_gemma":[0.00276032,0.02589446,0.2055385,0.06732277,0.01476506,0.03779848,0.001457201,0.001314235,0.009963014,0.009544831,0.6234488,0.0001921944],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03203388,0.9512971,0.00128075,0.002633265,0.0007831908,0.0002960819,0.0006301986,0.00002448126,0.01102108],"genre_scores_gemma":[0.2437141,0.7259756,0.01245995,0.006071404,0.004346322,0.0006044545,0.001182034,0.00001949553,0.005626626],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006529001,"threshold_uncertainty_score":0.03452909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1593378217405332,"score_gpt":0.5388310450231255,"score_spread":0.3794932232825923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}